Experimental study demonstrates sunlight-driven scaffold diversification produces oxetane-rifamycins with potent anti-MRSA efficacy, highlighting a photochemical approach to antibiotic development.
Rifamycins display structural diversity and broad bioactivities, with the intrinsic reactivity of their polyketide chain and quinone ring providing a foundation for photochemical reactions. Herein, we constructed the mutant strain Δrif-orf3_16::rifR+rif-orf19 by deleting post-PKS modification genes of rifamycin, yielding 34a-deoxyrifamycin W (1a) and its derivatives (2a–4a). Subsequent sunlight irradiation of these compounds triggered an intramolecular Paternò–Büchi reaction coupled with Michael addition, producing oxetane-rifamycins A–D (1b–4b). They feature a unique 4/6/6/6/6/17 hexacyclic scaffold and exhibit potent anti-MRSA activity. Density functional theory (DFT) calculations elucidated the formation mechanism of the oxetane-rifamycin scaffold.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: